Christopher Simon - Jun 29, 2023 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
President & CEO, Director
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Simon
Stock symbol
HAE
Transactions as of
Jun 29, 2023
Transactions value $
-$4,352,981
Form type
4
Date filed
6/30/2023, 04:17 PM
Previous filing
May 19, 2023
Next filing
Mar 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Options Exercise $5.63M +197K +90.51% $28.62 414K Jun 29, 2023 Direct F1, F2
transaction HAE Common Stock Tax liability -$9.98M -118K -28.41% $84.84 296K Jun 29, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HAE Non-qualified Stock Option (Right to Buy) Options Exercise $0 -197K -100% $0.00* 0 Jun 29, 2023 Common Stock 197K $28.62 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an automatic exercise of options granted in 2016 and scheduled to expire after June 29, 2023, as reflected in this Form 4.
F2 This number includes unvested restricted stock units previously reported.
F3 Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.
F4 Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.